MedTrace Logo

Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH

NCT03179670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 625

Last updated 2019-06-19

No results posted yet for this study

Summary

The high level of unsatisfactory outcome observed in patients treated for LUTS associated with BPH with respect to the different existing therapeutic options strongly emphasizes the need for treatment optimisation in daily practice by a careful LUTS monitoring and treatment adjustment when needed. The poorer outcome observed in patients for whom treatment has been initiated recently suggests that the duration of the disease itself may influence the patient satisfaction.To achieve this goal, we propose to systematically assess LUTS associated with BPH in patients treated for at least 6 months and to assess whether an alpha-blocker therapy initiation/modification may improve the outcome in case of persisting symptoms. We also investigate the influence of the symptom duration on the frequency of unsatisfactory outcome.

Conditions

  • Benign Prostatic Hyperplasia

Sponsors & Collaborators

  • ClinSearch

    collaborator OTHER

  • RECORDATI GROUP

    lead INDUSTRY

Eligibility

Min Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03179670 on ClinicalTrials.gov